| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2022-03-07 02:51:55 UTC |
|---|
| HMDB ID | HMDB0015254 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Ambenonium |
|---|
| Description | Ambenonium is only found in individuals that have used or taken this drug. It is a cholinesterase inhibitor used in the management of myasthenia gravis. [Wikipedia ]Ambenonium exerts its actions against myasthenia gravis by competitive, reversible inhibition of acetylcholinesterase. The disease myasthenia gravis occurs when the body inappropriately produces antibodies against acetylcholine receptors, and thus inhibits proper acetylcholine signal transmission (when acetylcholine binds to acetylcholine receptors of striated muscle fibers, it stimulates those fibers to contract). Ambenonium reversibly binds acetylcholinesterase at the anionic site, which results in the blockage of the site of acetycholine binding, thereby inhibiting acetylcholine hydrolysis and enhancing cholinergic function through the accumulation of acetycholine at cholinergic synpases. In turn this facilitates transmission of impulses across the myoneural junction and effectively treats the disease. |
|---|
| Structure | CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC1=CC=CC=C1Cl InChI=1S/C28H40Cl2N4O2/c1-5-33(6-2,21-23-13-9-11-15-25(23)29)19-17-31-27(35)28(36)32-18-20-34(7-3,8-4)22-24-14-10-12-16-26(24)30/h9-16H,5-8,17-22H2,1-4H3/p+2 |
|---|
| Synonyms | | Value | Source |
|---|
| Ambenonium base | ChEBI | | Ambenonum | ChEBI | | Mytelase | HMDB | | Ambenonium chloride | HMDB | | Chloride, ambenonium | HMDB | | Sanofi winthrop brand OF ambenonium chloride | HMDB |
|
|---|
| Chemical Formula | C28H42Cl2N4O2 |
|---|
| Average Molecular Weight | 537.565 |
|---|
| Monoisotopic Molecular Weight | 536.268482022 |
|---|
| IUPAC Name | [(2-chlorophenyl)methyl](2-{[(2-{[(2-chlorophenyl)methyl]diethylazaniumyl}ethyl)carbamoyl]formamido}ethyl)diethylazanium |
|---|
| Traditional Name | ambenonium |
|---|
| CAS Registry Number | 7648-98-8 |
|---|
| SMILES | CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC1=CC=CC=C1Cl |
|---|
| InChI Identifier | InChI=1S/C28H40Cl2N4O2/c1-5-33(6-2,21-23-13-9-11-15-25(23)29)19-17-31-27(35)28(36)32-18-20-34(7-3,8-4)22-24-14-10-12-16-26(24)30/h9-16H,5-8,17-22H2,1-4H3/p+2 |
|---|
| InChI Key | OMHBPUNFVFNHJK-UHFFFAOYSA-P |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Alpha amino acid amides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-amino acid amide
- Benzylamine
- Phenylmethylamine
- Aralkylamine
- Chlorobenzene
- Halobenzene
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Tetraalkylammonium salt
- Quaternary ammonium salt
- Carboxamide group
- Secondary carboxylic acid amide
- Organic nitrogen compound
- Amine
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Organooxygen compound
- Organic salt
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organic cation
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 196 - 199 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 9.4e-07 g/L | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.54 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 17.6269 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.65 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 53.9 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2267.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 237.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 252.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 173.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 172.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 854.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 679.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 183.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1323.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 696.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1966.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 422.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 450.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 156.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 71.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Ambenonium,1TMS,isomer #1 | CC[N+](CC)(CCNC(=O)C(=O)N(CC[N+](CC)(CC)CC1=CC=CC=C1Cl)[Si](C)(C)C)CC1=CC=CC=C1Cl | 3922.2 | Semi standard non polar | 33892256 | | Ambenonium,1TMS,isomer #1 | CC[N+](CC)(CCNC(=O)C(=O)N(CC[N+](CC)(CC)CC1=CC=CC=C1Cl)[Si](C)(C)C)CC1=CC=CC=C1Cl | 3896.5 | Standard non polar | 33892256 | | Ambenonium,1TMS,isomer #1 | CC[N+](CC)(CCNC(=O)C(=O)N(CC[N+](CC)(CC)CC1=CC=CC=C1Cl)[Si](C)(C)C)CC1=CC=CC=C1Cl | 4974.6 | Standard polar | 33892256 | | Ambenonium,2TMS,isomer #1 | CC[N+](CC)(CCN(C(=O)C(=O)N(CC[N+](CC)(CC)CC1=CC=CC=C1Cl)[Si](C)(C)C)[Si](C)(C)C)CC1=CC=CC=C1Cl | 3898.8 | Semi standard non polar | 33892256 | | Ambenonium,2TMS,isomer #1 | CC[N+](CC)(CCN(C(=O)C(=O)N(CC[N+](CC)(CC)CC1=CC=CC=C1Cl)[Si](C)(C)C)[Si](C)(C)C)CC1=CC=CC=C1Cl | 3913.1 | Standard non polar | 33892256 | | Ambenonium,2TMS,isomer #1 | CC[N+](CC)(CCN(C(=O)C(=O)N(CC[N+](CC)(CC)CC1=CC=CC=C1Cl)[Si](C)(C)C)[Si](C)(C)C)CC1=CC=CC=C1Cl | 4640.4 | Standard polar | 33892256 | | Ambenonium,1TBDMS,isomer #1 | CC[N+](CC)(CCNC(=O)C(=O)N(CC[N+](CC)(CC)CC1=CC=CC=C1Cl)[Si](C)(C)C(C)(C)C)CC1=CC=CC=C1Cl | 4110.3 | Semi standard non polar | 33892256 | | Ambenonium,1TBDMS,isomer #1 | CC[N+](CC)(CCNC(=O)C(=O)N(CC[N+](CC)(CC)CC1=CC=CC=C1Cl)[Si](C)(C)C(C)(C)C)CC1=CC=CC=C1Cl | 4100.9 | Standard non polar | 33892256 | | Ambenonium,1TBDMS,isomer #1 | CC[N+](CC)(CCNC(=O)C(=O)N(CC[N+](CC)(CC)CC1=CC=CC=C1Cl)[Si](C)(C)C(C)(C)C)CC1=CC=CC=C1Cl | 4954.0 | Standard polar | 33892256 | | Ambenonium,2TBDMS,isomer #1 | CC[N+](CC)(CCN(C(=O)C(=O)N(CC[N+](CC)(CC)CC1=CC=CC=C1Cl)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC1=CC=CC=C1Cl | 4268.5 | Semi standard non polar | 33892256 | | Ambenonium,2TBDMS,isomer #1 | CC[N+](CC)(CCN(C(=O)C(=O)N(CC[N+](CC)(CC)CC1=CC=CC=C1Cl)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC1=CC=CC=C1Cl | 4268.2 | Standard non polar | 33892256 | | Ambenonium,2TBDMS,isomer #1 | CC[N+](CC)(CCN(C(=O)C(=O)N(CC[N+](CC)(CC)CC1=CC=CC=C1Cl)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC1=CC=CC=C1Cl | 4621.4 | Standard polar | 33892256 |
|
|---|
| NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|